Home > Cashflow Statement > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Cash Flow from Financing Activities

    Back to Cashflow Statement
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Financing Activities ₹-561 Cr₹-1,543 Cr₹-524 Cr₹-696 Cr₹-428 Cr

What is the latest Cash Flow from Financing Activities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Cash Flow from Financing Activities ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹-561 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Financing Activities
Mar2024₹-561 Cr
Mar2023₹-1,543 Cr
Mar2022₹-524 Cr
Mar2021₹-696 Cr
Mar2020₹-428 Cr

How is Cash Flow from Financing Activities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Cash Flow from Financing Activities % Change
Mar2024 ₹-561 Cr
Negative
Mar2023 ₹-1,543 Cr
Negative
Mar2022 ₹-524 Cr
Negative
Mar2021 ₹-696 Cr
Negative
Mar2020 ₹-428 Cr -

Compare Cash Flow from Financing Activities of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹35,408.0 Cr -6.3% -9.4% 4.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,936.0 Cr -5.8% -3.2% 35.1% Stock Analytics
DIVIS LABORATORIES ₹152,157.0 Cr -2.8% -3.6% 44.7% Stock Analytics
CIPLA ₹116,200.0 Cr -3.9% -0.5% 13.9% Stock Analytics
DR REDDYS LABORATORIES ₹111,325.0 Cr -1.2% 7.1% 17.8% Stock Analytics
ZYDUS LIFESCIENCES ₹98,037.4 Cr -2.7% -0.1% 40.9% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-6.3%

-9.4%

4.9%

SENSEX

-2.1%

-6.4%

7%


You may also like the below Video Courses